We Aspire To Cure Cancer Trademark Details

We Aspire to Cure Cancer was registered on Tuesday, January 19, 2010 and is currently owned by Millennium Pharmaceuticals, Inc. under the registration number 3739198 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 9 years ago on Friday, March 27, 2015, according to the United State Patent & Trademark Office
Word Mark We Aspire to Cure Cancer
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Millennium Pharmaceuticals, Inc. of Cambridge, MA

View all trademarks for Millennium Pharmaceuticals, Inc.
Other Trademarks for Millennium Pharmaceuticals, Inc.
Serial Number 77732357
Registration Number 3739198
Status Date Friday, March 27, 2015
Filing Date Friday, March 27, 2015
Registration Date Tuesday, January 19, 2010
Attorney Nancy C. DiConza

Correspondent

NANCY C. DICONZA
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLAZA
NEW YORK NY 10017-1822

Case File Statements

Goods & Services Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Tuesday, May 12, 2009
First Use Anywhere Sunday, March 15, 2009
First Use In Commerce Sunday, March 15, 2009
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.